Page 44 - AN-3-1

Advanced Neurology Antibodies as neurodegenerative biomarkers

Acknowledgments Res. 2015;63(1-3):18-25.

None. doi: 10.1007/s12026-015-8714-5
6. Prinz M, Priller J. The role of peripheral immune cells
Funding in the CNS in steady state and disease. Nat Neurosci.
This work was supported by part of the Grant 2017;20(2):136-144.
PID2 021-126434OB-I00 funded by MCIN/ doi: 10.1038/NN.4475
AEI/10.13039/501100011033 and ERDF A way of making 7. Ousman SS, Kubes P. Immune surveillance in the central
Europe. It was also funded by the Basque Government nervous system. Nat Neurosci. 2012;15(8):1096-1101.
(BIKAINTEK program: 005-B2/2021, 007-B2/2020; IT1706-
22 and PUE21-03) and the University of the Basque Country, doi: 10.1038/nn.3161
UPV/EHU (PIFIND21/04, PIFI20/05 and COLAB20/07). 8. Baruch K, Schwartz M. CNS-specific T cells shape brain
function via the choroid plexus. Brain Behav Immun.
Conflict of interest 2013;34:11-16.
The authors declare no conflicts of interest. doi: 10.1016/j.bbi.2013.04.002

Author contribution 9. Castellani G, Croese T, Peralta Ramos JM, Schwartz M.
Transforming the understanding of brain immunity. Science.
Conceptualization: June Egiguren-Ortiz 2023;380(6640):eabo7649.
Writing – original draft: All authors doi: 10.1126/SCIENCE.ABO7649
Writing – review and editing: All authors
10. Berriat F, Lobsiger CS, Boillée S. The contribution of the
Ethics approval and consent to participate peripheral immune system to neurodegeneration. Nat
Neurosci. 2023;26(6):942-954.
Not applicable.
doi: 10.1038/S41593-023-01323-6
Consent for publication 11. Lueg G, Gross CC, Lohmann H, et al. Clinical relevance of
Not applicable. specific T-cell activation in the blood and cerebrospinal fluid
of patients with mild Alzheimer’s disease. Neurobiol Aging.
Availability of data 2015;36(1):81-89.
Not applicable. doi: 10.1016/j.neurobiolaging.2014.08.008
12. Gate D, Saligrama N, Leventhal O, et al. Clonally expanded
References CD8 T cells patrol the cerebrospinal fluid in Alzheimer’s
1. Engelhardt B, Vajkoczy P, Weller RO. The movers and disease. Nature. 2020;577(7790):399-404.
shapers in immune privilege of the CNS. Nat Immunol. doi: 10.1038/s41586-019-1895-7
2017;18(2):123-131.
13. Zhang J, Ke KF, Liu Z, Qiu YH, Peng YP. Th17 Cell-mediated
doi: 10.1038/ni.3666 neuroinflammation is involved in neurodegeneration of
2. Croese T, Castellani G, Schwartz M. Immune cell Aβ1-42-induced Alzheimer’s disease model rats. PLoS One.
compartmentalization for brain surveillance and protection. 2013;8(10):e75786.
Nat Immunol. 2021;22(9):1083-1092. doi: 10.1371/journal.pone.0075786
doi: 10.1038/s41590-021-00994-2 14. Monsonego A, Nemirovsky A, Harpaz I. CD4 T cells in
3. Fainstein N, Ben-Hur T. Brain region-dependent rejection immunity and immunotherapy of Alzheimer’s disease.
of neural precursor cell transplants. Front Mol Neurosci. Immunology. 2013;139(4):438-446.
2018;11:136. doi: 10.1111/imm.12103
doi: 10.3389/fnmol.2018.00136 15. Bouras C, Riederer BM, Kövari E, Hof PR, Giannakopoulos P.
4. Zamvil SS, Steinman L. The T lymphocyte in experimental Humoral immunity in brain aging and Alzheimer’s disease.
allergic encephalomyelitis. Annu Rev Immunol. 1990;8(1):579- Brain Res Brain Res Rev. 2005;48(3):477-487.
621. doi: 10.1016/j.brainresrev.2004.09.009
doi: 10.1146/annurev.iy.08.040190.003051
16. Marsh SE, Abud EM, Lakatos A, et al. The adaptive immune
5. Kowal C, Athanassiou A, Chen H, Diamond B. Maternal system restrains Alzheimer’s disease pathogenesis by
antibodies and developing blood-brain barrier. Immunol modulating microglial function. Proc Natl Acad Sci U S A.

Volume 3 Issue 1 (2024) 9 https://doi.org/10.36922/an.2058